Theranostics 2020; 10(5):2402-2404. doi:10.7150/thno.43075 This issue Cite

Erratum

Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum

Siwen Li1, Yuxi Liu1, Yalan Rui1, Liping Tang2, Samuel Achilefu3, Yueqing Gu1,✉

1. Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24th Tong Jia street, Nanjing 210009, Jiangsu Province, China. Phone: 86-25-83271046; Fax: 86-25-83271046.
2. Department of Bioengineering, University of Texas at Arlington, Arlington, TX, USA.
3. Department of Radiology, School of Medicine, Washington University in St. Louis, MO, USA

Citation:
Li S, Liu Y, Rui Y, Tang L, Achilefu S, Gu Y. Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum. Theranostics 2020; 10(5):2402-2404. doi:10.7150/thno.43075. https://www.thno.org/v10p2402.htm
Other styles

File import instruction

Corrected-article in Theranostics, Volume 8, 2621


Citation styles

APA
Li, S., Liu, Y., Rui, Y., Tang, L., Achilefu, S., Gu, Y. (2020). Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum. Theranostics, 10(5), 2402-2404. https://doi.org/10.7150/thno.43075.

ACS
Li, S.; Liu, Y.; Rui, Y.; Tang, L.; Achilefu, S.; Gu, Y. Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum. Theranostics 2020, 10 (5), 2402-2404. DOI: 10.7150/thno.43075.

NLM
Li S, Liu Y, Rui Y, Tang L, Achilefu S, Gu Y. Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum. Theranostics 2020; 10(5):2402-2404. doi:10.7150/thno.43075. https://www.thno.org/v10p2402.htm

CSE
Li S, Liu Y, Rui Y, Tang L, Achilefu S, Gu Y. 2020. Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum. Theranostics. 10(5):2402-2404.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image